Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade

Shares of Terns Pharmaceuticals, Inc. (TERN) have gained 3.8% over the past four weeks to close the last trading session at $6.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$14.21 indicates a potential upside of 136.4%. The mean estimate comprises seven short-term price targets with a standard deviation of $5.92. While the lowest estimate of$5.50 indicates an 8.5% decline ...